CN Stock MarketDetailed Quotes

605116 Aurisco Pharmaceutical

Watchlist
  • 22.60
  • -0.57-2.46%
Market Closed May 23 15:00 CST
9.18BMarket Cap28.18P/E (TTM)

Aurisco Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
11.08%335.62M
25.24%1.26B
19.97%922.53M
8.59%552.65M
38.07%302.14M
25.48%1.01B
30.53%768.96M
26.67%508.94M
17.45%218.83M
11.36%803.36M
Operating revenue
11.08%335.62M
25.24%1.26B
19.97%922.53M
8.59%552.65M
38.07%302.14M
25.48%1.01B
30.53%768.96M
26.67%508.94M
17.45%218.83M
11.36%803.36M
Other operating revenue
----
18.90%8.59M
----
99.57%6.8M
----
149.00%7.23M
----
54.67%3.41M
----
-21.48%2.9M
Total operating cost
-2.81%237.89M
25.92%957.3M
24.65%692.61M
19.63%437.18M
44.60%244.77M
22.39%760.23M
25.79%555.66M
18.01%365.44M
11.52%169.27M
14.92%621.17M
Operating cost
-5.49%155.46M
14.12%556.56M
5.95%409.24M
12.33%277.47M
69.51%164.48M
19.34%487.68M
28.80%386.26M
14.16%247.01M
-8.98%97.04M
7.39%408.64M
Operating tax surcharges
50.79%3.67M
28.93%9.84M
19.14%6.39M
40.10%4.29M
70.18%2.44M
11.40%7.63M
10.38%5.36M
-4.02%3.07M
4.38%1.43M
12.83%6.85M
Operating expense
124.84%24.13M
152.81%100.78M
134.92%67.24M
32.11%25.86M
15.85%10.73M
34.22%39.86M
31.98%28.62M
35.31%19.58M
41.65%9.26M
39.13%29.7M
Administration expense
-1.38%37.34M
25.33%169.71M
39.65%121.3M
47.99%81.84M
31.12%37.86M
27.39%135.41M
17.59%86.86M
19.17%55.3M
21.10%28.88M
45.74%106.3M
Financial expense
-429.60%-11.64M
40.37%-16.47M
77.46%-7.36M
45.41%-8.2M
628.89%3.53M
-8,331.33%-27.61M
-5,223.22%-32.64M
-1,298.99%-15.02M
-72.72%484.61K
-97.27%335.44K
-Interest expense (Financial expense)
10.09%590.31K
171.25%2.74M
--1.63M
--1.27M
171.87%536.18K
57.16%1.01M
----
----
--197.22K
--643.75K
-Interest Income (Financial expense)
-572.36%-7.82M
-274.80%-16.53M
7.86%-3.08M
20.39%-2.13M
-12.05%-1.16M
46.65%-4.41M
-11.56%-3.34M
9.21%-2.68M
-50.05%-1.04M
-51.37%-8.27M
Research and development
12.50%28.93M
16.73%136.89M
17.98%95.78M
0.74%55.91M
-20.09%25.72M
69.09%117.26M
98.93%81.19M
98.47%55.5M
176.29%32.18M
46.45%69.35M
Credit Impairment Loss
161.28%596.14K
-17.37%-4.9M
31.82%-3.68M
107.97%227.61K
-602.61%-972.77K
-398.72%-4.17M
-499.81%-5.4M
-481.98%-2.85M
119.36%193.54K
288.70%1.4M
Asset Impairment Loss
----
2.24%-7.66M
----
--15.99K
----
---7.83M
----
----
----
----
Other net revenue
69.74%2.72M
488.09%25.5M
1,371.96%35.41M
-36.85%2.5M
-58.56%1.6M
-157.46%-6.57M
-69.50%2.41M
-38.65%3.95M
-34.43%3.87M
80.12%11.43M
Fair value change income
----
----
-7,355.96%-1.23M
-9,103.85%-2.22M
----
----
-90.52%16.92K
-82.56%24.63K
----
----
Invest income
215.35%476.85K
2,774.18%31.72M
12,169.69%32.82M
387.64%824.64K
---413.4K
-275.20%-1.19M
-41.65%267.45K
-42.05%169.11K
----
-71.33%677.09K
Asset deal income
-627.30%-286.29K
-2.18%-1.53M
4,052.92%1.28M
-480.70%-353.57K
-222.38%-39.36K
-277.18%-1.5M
90.07%-32.27K
434.78%92.87K
149.06%32.16K
-52.22%-396.48K
Other revenue
-36.16%1.93M
-3.22%7.86M
-17.57%6.23M
-38.67%4M
-16.84%3.03M
-16.80%8.12M
21.43%7.56M
23.27%6.52M
-46.67%3.64M
75.16%9.76M
Operating profit
70.33%100.45M
37.07%330.73M
23.01%265.33M
-20.00%117.96M
10.38%58.97M
24.61%241.28M
38.96%215.7M
49.61%147.45M
32.14%53.43M
3.39%193.62M
Add:Non operating Income
823.54%9.24K
-3.65%11.37K
38.02%7.14K
66.55%4.45K
24.91%1K
-75.31%11.8K
-80.86%5.17K
-80.54%2.67K
-60.98%800.59
-93.42%47.79K
Less:Non operating expense
488.04%1.35M
209.15%1.66M
0.90%538.36K
-36.81%256.52K
367.58%229.58K
-67.62%536.53K
-63.83%533.55K
7.81%405.96K
-81.04%49.1K
-26.63%1.66M
Total profit
68.71%99.11M
36.69%329.08M
23.06%264.8M
-19.95%117.71M
10.06%58.74M
25.38%240.75M
39.93%215.18M
49.75%147.05M
32.86%53.38M
3.38%192.01M
Less:Income tax cost
29.85%16.92M
23.21%40.01M
8.74%32.07M
-32.42%20.86M
1.50%13.03M
36.85%32.47M
42.68%29.49M
102.87%30.87M
68.94%12.84M
-16.77%23.73M
Net profit
79.79%82.18M
38.79%289.07M
25.34%232.73M
-16.64%96.85M
12.77%45.71M
23.77%208.28M
39.50%185.68M
40.01%116.18M
24.44%40.54M
7.03%168.28M
Net profit from continuing operation
79.79%82.18M
38.79%289.07M
25.34%232.73M
-16.64%96.85M
12.77%45.71M
23.77%208.28M
39.50%185.68M
40.01%116.18M
24.44%40.54M
7.03%168.28M
Less:Minority Profit
----
86.97%-349.87K
125.57%182.26K
269.36%952.35K
47.29%-166.98K
-520.88%-2.69M
-73.60%-712.71K
---562.32K
---316.76K
---432.53K
Net profit of parent company owners
79.14%82.18M
37.19%289.42M
24.76%232.55M
-17.85%95.9M
12.30%45.88M
25.04%210.96M
39.60%186.39M
40.69%116.74M
25.42%40.85M
7.31%168.71M
Earning per share
Basic earning per share
81.82%0.2
36.54%0.71
23.91%0.57
-17.24%0.24
10.00%0.11
23.81%0.52
39.39%0.46
38.10%0.29
25.00%0.1
0.00%0.42
Diluted earning per share
81.82%0.2
36.54%0.71
23.91%0.57
-17.24%0.24
10.00%0.11
23.81%0.52
39.39%0.46
38.10%0.29
25.00%0.1
0.00%0.42
Other composite income
116.32%34.43K
948.80%21.99M
-41.10%1.3M
-76.68%242.19K
23.78%-211.03K
624.97%2.1M
1,114.43%2.21M
576.87%1.04M
-276.88K
-364.26%-399.39K
Other composite income of parent company owners
116.32%34.43K
948.80%21.99M
-41.10%1.3M
-76.68%242.19K
23.78%-211.03K
624.97%2.1M
1,114.43%2.21M
576.87%1.04M
---276.88K
-364.26%-399.39K
Total composite income
80.70%82.22M
47.86%311.06M
24.56%234.03M
-17.17%97.09M
13.02%45.5M
25.31%210.38M
41.39%187.89M
41.63%117.21M
23.59%40.26M
6.67%167.88M
Total composite income of parent company owners
80.04%82.22M
46.16%311.41M
23.99%233.85M
-18.37%96.14M
12.55%45.67M
26.59%213.06M
41.49%188.6M
42.31%117.78M
24.57%40.58M
6.95%168.31M
Total composite income of minority owners
----
86.97%-349.87K
125.57%182.26K
269.36%952.35K
47.29%-166.98K
-520.88%-2.69M
-73.60%-712.71K
---562.32K
---316.76K
---432.53K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 11.08%335.62M25.24%1.26B19.97%922.53M8.59%552.65M38.07%302.14M25.48%1.01B30.53%768.96M26.67%508.94M17.45%218.83M11.36%803.36M
Operating revenue 11.08%335.62M25.24%1.26B19.97%922.53M8.59%552.65M38.07%302.14M25.48%1.01B30.53%768.96M26.67%508.94M17.45%218.83M11.36%803.36M
Other operating revenue ----18.90%8.59M----99.57%6.8M----149.00%7.23M----54.67%3.41M-----21.48%2.9M
Total operating cost -2.81%237.89M25.92%957.3M24.65%692.61M19.63%437.18M44.60%244.77M22.39%760.23M25.79%555.66M18.01%365.44M11.52%169.27M14.92%621.17M
Operating cost -5.49%155.46M14.12%556.56M5.95%409.24M12.33%277.47M69.51%164.48M19.34%487.68M28.80%386.26M14.16%247.01M-8.98%97.04M7.39%408.64M
Operating tax surcharges 50.79%3.67M28.93%9.84M19.14%6.39M40.10%4.29M70.18%2.44M11.40%7.63M10.38%5.36M-4.02%3.07M4.38%1.43M12.83%6.85M
Operating expense 124.84%24.13M152.81%100.78M134.92%67.24M32.11%25.86M15.85%10.73M34.22%39.86M31.98%28.62M35.31%19.58M41.65%9.26M39.13%29.7M
Administration expense -1.38%37.34M25.33%169.71M39.65%121.3M47.99%81.84M31.12%37.86M27.39%135.41M17.59%86.86M19.17%55.3M21.10%28.88M45.74%106.3M
Financial expense -429.60%-11.64M40.37%-16.47M77.46%-7.36M45.41%-8.2M628.89%3.53M-8,331.33%-27.61M-5,223.22%-32.64M-1,298.99%-15.02M-72.72%484.61K-97.27%335.44K
-Interest expense (Financial expense) 10.09%590.31K171.25%2.74M--1.63M--1.27M171.87%536.18K57.16%1.01M----------197.22K--643.75K
-Interest Income (Financial expense) -572.36%-7.82M-274.80%-16.53M7.86%-3.08M20.39%-2.13M-12.05%-1.16M46.65%-4.41M-11.56%-3.34M9.21%-2.68M-50.05%-1.04M-51.37%-8.27M
Research and development 12.50%28.93M16.73%136.89M17.98%95.78M0.74%55.91M-20.09%25.72M69.09%117.26M98.93%81.19M98.47%55.5M176.29%32.18M46.45%69.35M
Credit Impairment Loss 161.28%596.14K-17.37%-4.9M31.82%-3.68M107.97%227.61K-602.61%-972.77K-398.72%-4.17M-499.81%-5.4M-481.98%-2.85M119.36%193.54K288.70%1.4M
Asset Impairment Loss ----2.24%-7.66M------15.99K-------7.83M----------------
Other net revenue 69.74%2.72M488.09%25.5M1,371.96%35.41M-36.85%2.5M-58.56%1.6M-157.46%-6.57M-69.50%2.41M-38.65%3.95M-34.43%3.87M80.12%11.43M
Fair value change income ---------7,355.96%-1.23M-9,103.85%-2.22M---------90.52%16.92K-82.56%24.63K--------
Invest income 215.35%476.85K2,774.18%31.72M12,169.69%32.82M387.64%824.64K---413.4K-275.20%-1.19M-41.65%267.45K-42.05%169.11K-----71.33%677.09K
Asset deal income -627.30%-286.29K-2.18%-1.53M4,052.92%1.28M-480.70%-353.57K-222.38%-39.36K-277.18%-1.5M90.07%-32.27K434.78%92.87K149.06%32.16K-52.22%-396.48K
Other revenue -36.16%1.93M-3.22%7.86M-17.57%6.23M-38.67%4M-16.84%3.03M-16.80%8.12M21.43%7.56M23.27%6.52M-46.67%3.64M75.16%9.76M
Operating profit 70.33%100.45M37.07%330.73M23.01%265.33M-20.00%117.96M10.38%58.97M24.61%241.28M38.96%215.7M49.61%147.45M32.14%53.43M3.39%193.62M
Add:Non operating Income 823.54%9.24K-3.65%11.37K38.02%7.14K66.55%4.45K24.91%1K-75.31%11.8K-80.86%5.17K-80.54%2.67K-60.98%800.59-93.42%47.79K
Less:Non operating expense 488.04%1.35M209.15%1.66M0.90%538.36K-36.81%256.52K367.58%229.58K-67.62%536.53K-63.83%533.55K7.81%405.96K-81.04%49.1K-26.63%1.66M
Total profit 68.71%99.11M36.69%329.08M23.06%264.8M-19.95%117.71M10.06%58.74M25.38%240.75M39.93%215.18M49.75%147.05M32.86%53.38M3.38%192.01M
Less:Income tax cost 29.85%16.92M23.21%40.01M8.74%32.07M-32.42%20.86M1.50%13.03M36.85%32.47M42.68%29.49M102.87%30.87M68.94%12.84M-16.77%23.73M
Net profit 79.79%82.18M38.79%289.07M25.34%232.73M-16.64%96.85M12.77%45.71M23.77%208.28M39.50%185.68M40.01%116.18M24.44%40.54M7.03%168.28M
Net profit from continuing operation 79.79%82.18M38.79%289.07M25.34%232.73M-16.64%96.85M12.77%45.71M23.77%208.28M39.50%185.68M40.01%116.18M24.44%40.54M7.03%168.28M
Less:Minority Profit ----86.97%-349.87K125.57%182.26K269.36%952.35K47.29%-166.98K-520.88%-2.69M-73.60%-712.71K---562.32K---316.76K---432.53K
Net profit of parent company owners 79.14%82.18M37.19%289.42M24.76%232.55M-17.85%95.9M12.30%45.88M25.04%210.96M39.60%186.39M40.69%116.74M25.42%40.85M7.31%168.71M
Earning per share
Basic earning per share 81.82%0.236.54%0.7123.91%0.57-17.24%0.2410.00%0.1123.81%0.5239.39%0.4638.10%0.2925.00%0.10.00%0.42
Diluted earning per share 81.82%0.236.54%0.7123.91%0.57-17.24%0.2410.00%0.1123.81%0.5239.39%0.4638.10%0.2925.00%0.10.00%0.42
Other composite income 116.32%34.43K948.80%21.99M-41.10%1.3M-76.68%242.19K23.78%-211.03K624.97%2.1M1,114.43%2.21M576.87%1.04M-276.88K-364.26%-399.39K
Other composite income of parent company owners 116.32%34.43K948.80%21.99M-41.10%1.3M-76.68%242.19K23.78%-211.03K624.97%2.1M1,114.43%2.21M576.87%1.04M---276.88K-364.26%-399.39K
Total composite income 80.70%82.22M47.86%311.06M24.56%234.03M-17.17%97.09M13.02%45.5M25.31%210.38M41.39%187.89M41.63%117.21M23.59%40.26M6.67%167.88M
Total composite income of parent company owners 80.04%82.22M46.16%311.41M23.99%233.85M-18.37%96.14M12.55%45.67M26.59%213.06M41.49%188.6M42.31%117.78M24.57%40.58M6.95%168.31M
Total composite income of minority owners ----86.97%-349.87K125.57%182.26K269.36%952.35K47.29%-166.98K-520.88%-2.69M-73.60%-712.71K---562.32K---316.76K---432.53K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg